Form 4 for ACH ACCENDRA HEALTH INC/VA/
Accepted 2021-11-04 00:00:00 ET · period of report 2021-11-03 · accession 0001062993-21-010283 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-11-04 | 2021-11-03 | ACH | Pesicka Edward A | Pres, CEO, Dir | S - Sale | $41.98 | -56.6K | 1.26M | -4% | -$2.38M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-03 | S | D | 23,728 | $41.63 | 1,293,100 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. (F3) Weighted average of the sale price range of $41.11 through $42.10 |
| 2 | Common | Common Stock | 2021-11-03 | S | D | 3,598 | $40.31 | 1,316,828 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. (F2) Weighted average of the sale price range of $40.00 through $40.90 |
| 3 | Common | Common Stock | 2021-11-03 | S | D | 29,315 | $42.46 | 1,263,785 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 5, 2021. (F4) Weighted average of the sale price range of $42.12 through $42.90 |